Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

The FDA has approved its first at-home, nondrug therapy for depression, with a wearable brain stimulation headset developed by Flow Neuroscience. The agency issued a green light that covers the device ...

Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...

The average one-year price target for Charter Communications (XTRA:CQD) has been revised to 294,94 € / share. This is a decrease of 12.90% from the prior estimate of 338,64 € dated November 9, 2025.

Methane (CH₄), the colorless and odorless gas that makes up most natural gas on Earth, has so far been converted into useful fuels and chemicals via energy-intensive processes that need to be carried ...

Andrew Kessel was a breaking news writer for Investopedia until October 2025. He previously covered markets for Proactive Investors, with a focus on small-cap stocks in fintech, healthcare, mining, ...

There comes a time before every big purchase when you might ask yourself, “Do I really need this?” If you don’t pause for a moment — and if you tend to blow your budget as a result — then you need to ...

Chart Industries and Flowserve recently agreed to merge in an all-stock deal. The two companies outlined significant revenue and cost synergies. Strangely, both bargain-priced stocks fell after the ...

June 4 (Reuters) - U.S.-based equipment manufacturer Chart Industries (GTLS.N), opens new tab and flow control systems maker Flowserve Corp (FLS.N), opens new tab agreed to merge in an all-stock deal, ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion. Chart shareholders will receive 3.165 shares of Flowserve ...